Lexicon Pharmaceuticals
LXRX
#6424
Rank
A$1.17 B
Marketcap
A$2.64
Share price
-2.36%
Change (1 day)
129.12%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): A-$0.30

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.27. In 2024 the company made an earnings per share (EPS) of A-$0.91 an increase over its 2023 EPS that were of A-$1.13.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.30-66.69%
2024A-$0.91-20%
2023A-$1.1331.15%
2022A-$0.86-0%
2021A-$0.8610.91%
2020A-$0.78-145.08%
2019A$1.73-206.09%
2018A-$1.63-5.74%
2017A-$1.73-10.95%
2016A-$1.942640%
2015A-$0.07088-96.34%
2014A-$1.93-2.53%
2013A-$1.98-9.09%
2012A-$2.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.83-9,689.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.84-3,010.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.29-22,484.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.66 3,115.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$8.93-3,415.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.71 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.06 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.98-836.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$108.74 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA